Wird geladen...
Evolving Role for Pharmacotherapy in NAFLD/NASH
Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent, dynamic disease that occurs across the age spectrum and can lead to cirrhosis and hepatocellular carcinoma. There are currently no US Food and Drug Administration (FDA) approved treatments for NAFLD; however, this is a field of active r...
Gespeichert in:
| Veröffentlicht in: | Clin Transl Sci |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7877845/ https://ncbi.nlm.nih.gov/pubmed/32583961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12839 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|